
DeFloria Achieves Ground-Breaking Milestone in Botanical Drug Development
Last month, DeFloria Inc.—a joint venture between Ajna BioSciences PBC and Charlotte’s Web Holdings Inc.—announced a milestone in its development of an oral multi-cannabinoid drug for the treatment of symptoms of autism spectrum disorder (ASD). In a first …